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Abstract
Background: Quality of life (QOL) is a core outcome of palliative care, yet in African settings there is a lack of
evidence on patients’ levels of QOL. We aimed to describe QOL among patients with incurable, progressive disease
receiving palliative care in South Africa and Uganda, to compare QOL in cancer and HIV, to determine how
domains of QOL correlate with overall QOL, and compare levels of QOL in this population with those in other
studies using the same tool.
Methods: A cross-sectional survey was conducted using the Missoula Vitas Quality of Life Index (MVQOLI), a
26-item QOL questionnaire with five subscales (Function, Symptom, Interpersonal, Well being, Transcendent) covering
physical, social, psychological and spiritual domains and one global QOL item. One item in each subscale assesses
the subjective importance of the domain on a score from 1 (least important) to 5 (most important), used to weight
the contribution of the subscale towards the Total QOL score. The tool was translated into 6 languages and
administered to consecutively recruited patients at four facilities in South Africa and one in Uganda.
Results: 285 patients were recruited, with a mean age of 40.1; 197 (69.1%) were female. Patients’ primary
diagnoses were HIV (80.7%), cancer (17.9%) and other conditions (1.4%). The mean global QOL score was 2.81
(possible range 0 (worst) to 5 (best)); mean Total score 17.32 (possible range 0 to 30). Patients scored most poorly
on Function (mean 0.21), followed by Well being (2.59), Symptoms (5.38), Transcendent (5.50), Interpersonal (9.53)
(possible range for subscale scores -30 to 30). Most important to patients were: close relationships (mean 4.13),
feeling at peace (4.12), sense of meaning in life (4.10), being active (3.84), physical comfort (2.58). Cancer patients
were predominantly recruited at three of the sites; hence comparison with HIV-infected patients was restricted to
these sites. HIV+ patients (n = 115) scored significantly worse than cancer patients (n = 50) on Well being (Z =
-2.778, p = 0.005), Transcendence (Z = -2.693, p = 0.007) and Total QOL (Z = -2.564, p = 0.01). Global QOL score was
most weakly correlated with Total QOL (r = 0.37) and the Transcendent subscale was most highly correlated (r =
0.77) (both p < 0.001). Patients receiving palliative care in South Africa and Uganda exhibited significantly poorer
QOL compared to similar populations in the USA.
Conclusions: Feeling at peace and having a sense of meaning in life were more important to patients than being
active or physical comfort, and spiritual wellbeing correlated most highly with overall QOL. It is therefore vital to
identify and meet the psychological and spiritual care needs of patients, as well as to assess and treat pain and
other symptoms. Our finding that patients scored most poorly on the Function domain warrants further research.
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The burden of progressive, life-limiting disease in sub-
Saharan Africa is reflected in the epidemiology of HIV
[1,2] and cancer [3]. In sub-Saharan Africa in 2007 there
were 22.5 million people living with HIV infection;
1.7 million adults and children became infected with
HIV; and 1.6 million died of AIDS [1]. In addition, cancer
and other non-communicable diseases are becoming
urgent public health issues in the region. Parkin et al.
report that approximately one in five deaths in sub-
Saharan Africa is due to cancer; by 2050, the lifetime risk
of cancer is expected to increase by 50-60%, and
the annual number of cases to rise from 650, 000 to
2.2 million [4]. The burden of other progressive non-
malignant diseases is unknown.
Palliative care is therefore an essential component of
public health services in sub-Saharan Africa; however,
current provision in the region is patchy, and coverage is
poor [5,6]. Successful models of community- and home-
based palliative care in the region have been described,
b u ta l s os i g n i f i c a n tc h a l l e n g e s ,[ 5 ]i n c l u d i n gl a c ko f
access to essential drugs [7], poor social conditions, [8]
high morbidity and mortality in health workers, [9] and a
lack of trained palliative care professionals [10].
Despite these difficulties, Uganda and South Africa are
internationally recognised to have made sustained gains in
the provision of palliative care, largely through commu-
nity-based hospices and home-based palliative care
services. Uganda was the first country in Africa to make
palliative care for people with HIV and cancer a priority in
its National Health Plan (2001-2005) [11]. Oral morphine
is available in districts with specialist palliative care clini-
cians, and nurse prescribing is legislated, [12] although
problems with morphine roll-out are documented [13].
In South Africa, progress has involved the inclusion of
morphine as an essential drug in primary care, with
national standards for cancer pain management [14,15].
The first palliative care services were hospices founded
in the 1980s in line with UK models; [14] however, pal-
liative care is now provided through hospitals and
home-care providers across the country. South Coast
H o s p i c e( o n eo fo u rp a r t i c i p ating facilities) has pio-
neered the successful Integrated Community-based
Home Care (ICHC) model, [16] and a national network
of hospices operates according to accredited standards.
The first fully integrated public sector palliative care ser-
vice has also been launched in the largest hospital in
South Africa [17].
A major barrier to the further development of palliative
care in sub-Saharan Africa is the lack of data to inform
service provision [10,18]. Palliative care research in Africa
has predominantly focussed on opioid availability and
physical aspects of care, such as the assessment of pain
and other symptoms, while neglecting holistic outcomes
such as quality of life (QOL). QOL is defined by the
World Health Organization as ‘an individual’s perception
of their position in life, in the context of the culture and
value systems in which they live and in relation to their
goals, expectations, standards and concerns.’ [19] In
developed country settings, QOL assessment has become
increasingly important as healthcare providers attempt to
understand the impact of healthcare interventions on
patients’ lives rather than solely their physical outcomes
[20]. In particular, the main focus of palliative care is to
improve the QOL of patients and their families who face
the problems associated with life-limiting illness [21].
This includes meeting patients’ social, spiritual and
psychological needs as well as alleviating pain and other
physical symptoms [22]. In the developed world there
has been rapid growth in QOL research that aims to
understand patient experience, identify patient needs and
evaluate the effectiveness of interventions and services
[21,23,24]. However, to date there has been very little
research in this area in Africa, [5,18] despite recognition
of the importance of outcome measurement and the
need to identify domains in which patients may need
specific support [25,26]. Poverty, HIV stigma and multi-
ple AIDS deaths within the same family are common in
sub-Saharan Africa, [27-29] and likely to impact on QOL,
hence findings from high income countries are unlikely
to be applicable in the African context.
Few studies have examined QOL and non-physical
aspects of the experience of serious illness in Africa,
with some exceptions. Qualitative research has identified
a need for improved communication [30], financial sup-
port and good symptom control [31] in sub-Saharan
palliative care settings. In HIV infected populations in
sub-Saharan Africa, high levels of both physical and psy-
chological symptoms have been reported, [32,33] and
significantly lower scores on QOL as measured by the
MOS-HIV, than in non-infected populations [34]. How-
ever, a limitation of the MOS-HIV is its omission of
items relating to spiritual well being, a unique predictor
of QOL in other settings [35]. Poor QOL has also been
found among patients with HIV in South Africa (N =
607) [36] using the WHOQOL-HIV [37,38]. However,
the WHOQOL-HIV is a 100-item questionnaire with an
additional 38 importance items, and is reported to take
45-60 minutes to complete [37-40]. This makes the tool
overly burdensome for research with unwell palliative
care participants [41,42]. In Uganda, a Luganda version
o ft h eM i s s o u l aV i t a sQ u a l i t yo fL i f eI n d e x( M V Q O L I ) ,
a 26-item measure originally developed and validated in
the USA [43], was administered by Namisango et al to
200 patients with advanced AIDS in urban Kampala
[44]. The authors found the poorest QOL in the
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cal symptoms. However, these studies [32-34,44] focus
on HIV-infected patients, and levels of QOL in samples
that represent the range of clinical and demographic
characteristics of patients seen by palliative care services
in South Africa and Uganda are not known.
The primary aim of this study was therefore to describe
QOL among patients with incurable, progressive disease
receiving palliative care in South Africa and Uganda in
order to inform clinical care. Secondary aims were to com-
pare QOL in patients with cancer and patients with HIV
in our sample, to determine the association between sub-
scale scores and Total QOL score, and to compare levels
of QOL in this population with the findings of previous
studies using the MVQOLI in the USA and Uganda.
Methods
Study design
The study we report here is a component of a large,
30-month collaborative project, the Encompass project.
During the Encompass project qualitative and quantita-
tive data was collected in four phases during the valida-
tion and testing of the APCA African POS [30,45,46]. In
the phase reported here, we conducted a cross-sectional
survey using the MVQOLI at three non-profit palliative
care services and one state service in South Africa and
one voluntary sector hospice service in Uganda.
Participating services
Criteria for selecting the five participating sites were:
established palliative care services able to support
research and fulfil recruitment criteria for the study, and
representing a range of service types (home-based care
and inpatient units) and locations (rural, urban township
and urban), in order to enhance the generalisability of
findings [47]. All services aimed to offer holistic pallia-
tive care in line with the WHO definition [22], provided
by multi-professional teams that included medical doc-
tors, registered nurses, caregivers/nursing assistants,
social workers and (at two sites) counsellors. All services
also had access to spiritual care providers (who were
paid staff, trained volunteers or community providers).
Table 1 shows further details of the services.
Subjects and recruitment
We included participants in the study if they were adult
(at least 18 years old) patients, able to give informed
consent, judged to be physically and mentally well
enough to participate by their clinical staff, and able to
speak either English or one of six local languages flu-
ently (isiXhosa, isiZulu (Gauteng and KwaZulu Natal
dialects), SeSotho, SeTswana, Luganda, and Runyoro).
The target sample was 60 patients per site, giving a total
of approximately 300. This was considered a feasible
target given the time available and the size of the ser-
vices, and a sufficiently large sample size to meet the
aims of the study.
We recruited patients consecutively at the five participat-
ing services, named sites A-E for the purposes of reporting.
A trained researcher was based at each site (GA, TM, KM,
and two others - see Acknowledgements). At each service,
either clinical staff or the researcher approached eligible
patients, either on home visits or in the ward. Site A also
recruited existing patients by telephone. Service staff
or affiliated university departments translated information
sheets and consent forms from English into appropriate
local languages (see Data collection). We obtained
informed written consent prior to the interview; illiterate
participants were read the information sheet and consent
form and marked rather than signed their consent using a
thumb print or symbol (e.g. a cross) [48,49]. All patients
were informed that refusal to participate would not affect
their care in any way.
The study was reviewed and approved by the Ethical
Review Boards of the Universities of Cape Town
(128/2006), KwaZulu Natal (E025/06) and Witwaters-
rand (M060366), the Ugandan National Council for
Science and Technology (HS143), Hospice Africa
Uganda, and the Hospice Palliative Care Association of
South Africa (001/06).
Data collection
Instruments
Missoula Vitas Quality of Life Index (MVQOLI) The
MVQOLI was developed by Byock and colleagues to
measure adaptation to, and integration of, physical and
functional decline, as well as attainment of tasks of life
completion and life closure in advanced disease [43,50].
The tool contains 26 items: one global QOL item and
five subscales, consisting of five items per subscale:
Symptoms, Function, Interpersonal, Well being,a n d
Transcendent (see Table 2 for items). In general, the
Symptoms and Function subscales correspond to the
physical domain of patients’ illness experience, Interper-
sonal to the social domain, Well being to the psychologi-
cal and Transcendent to the spiritual. However, there is
some overlap between the psychological and the spiri-
tual, as the Well being subscale includes items related to
feeling at peace (items 17 and 20), which is arguably a
spiritual construct, [51] therefore we considered the
Well being subscale psycho-spiritual in nature.
The initial global QOL item is scored from 1 (worse
possible) to 5 (best possible). Within each subscale there
are two ‘assessment’ items and two ‘satisfaction’ items.
The final item in each subscale is a subjective measure of
that domain’s importance to the patient, the importance
score; from this score the contribution of the domain to
the patients’ overall QOL is calculated. In each subscale,
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tion items are scored from -4 to +4, in line with the
greater role of satisfaction (reflecting mastery and adapta-
tion) in the underlying theoretical construct [43]. The
average assessment scores and the average satisfaction
scores provide the unweighted dimensional scores, which
range from -6 to +6. Weighted dimensional subscores are
calculated by multiplying the sum of the average assess-
ment score plus the average satisfaction score by the
importance score (an integer between 1 and 5) in that
dimension; weighted subscores therefore range from -30
to +30. The Total QOL score is calculated by summing
the five weighted dimension scores, dividing the score by
10 and then adding 15, so that the resulting total falls
between 0 (worst QOL) and 30 (best QOL). The Total
QOL score therefore reflects the patient’s multidimen-
sional QOL weighted according to his/her own identifica-
tion of the most important dimensions. The MVQOLI
had adequate internal consistency (a = 0.77) and broad
construct validity (r = 0.43 Total score with global QOL)
among patients with a prognosis of six months or less at
community based hospices in the USA [43].
Although the MVQOLI was not developed for use in
Africa, it has been tested in a relevant population in
Uganda, one of the countries in which this study was
conducted. A slightly modified version of the tool (the
MVQOLI-M) was validated in advanced AIDS patients
in Uganda [44]. In this study we opted to use translated
versions of the original version of the tool for a number
of reasons. Firstly, only one of the five study centres was
in Uganda and, as South Africa is a more economically
developed nation, significant cultural differences were
anticipated between the country contexts. Secondly, for
the purposes of pooling the data from the five sites a
standardised questionnaire was needed; however, the
Ugandan version had changed the order of some of the
items, so could not be used as a direct equivalent to the
original. Thirdly, the Ugandan tool is in Luganda, which
was just one of the three Ugandan languages required
for data collection in this study. Fourthly, the Ugandan
validation made only a few minor changes to the word-
ing of items. Finally, the Ugandan version was validated
only in advanced AIDS patients, while our population of
interest was all patients seen by palliative care services
in South Africa and Uganda, including cancer and other
non-communicable diseases.
In order to assess whether or not the MVQOLI was
appropriate for measuring QOL in this context, we con-
ducted a factor analysis in a previous publication [52].
Principal component analysis and Varimax rotation
were used to determine whether the factor structure of
the tool in this study sample replicated the groupings of
the original tool dimensions [52]. The factor analysis
included all subscale items except the importance item
from each subscale, as we found these items behaved
differently. A 5-factor solution which closely resembled
the subscale structure of the tool accounted for 55% of
variance. Internal consistency of the tool using the origi-
nal scoring method and including all 25 subscale items
was a = 0.78 (subscales: Function a = 0.52, Symptoms
a = 0.41, Interpersonal a = 0.67, Well being a = 0.49,
Transcendent a = 0.54).
Table 1 Description of participating palliative care services
Site Area
served
Service type Source of most of funding No. of
patients
cared for
(2007-8)
Type of patients
cared for
Number of
patients
recruited
(total N = 285)
A Urban Home care, day care, outpatient clinic,
hospital consultancy, and outreach to
healthcare clinics through three
branches
Local, national, and
international donors
2396 Patients with
advanced cancer or
advanced HIV
63
B Urban
township
Four sister hospices, all offering short
term (2-3 week) inpatient care; two
also offer home care
Local, national, international
donors
1607 Patients with HIV,
cancer, or other
progressive incurable
conditions
62
C Urban
township
Home care, outpatient clinic, and
inpatient unit attached to hospital
Government and international
donors
1818 Patients with cancer,
HIV, or MND, from
diagnosis until point
of death
40
D Rural Home care and inpatient unit close to
hospital
Global Fund for AIDS,
Tuberculosis and Malaria
847 Patients with HIV, from
diagnosis until point
of death
60
E Rural, peri-
urban, and
urban
township
Home care, day care, and inpatient
unit
Local, national, and
international donors, including
Global Fund for AIDS,
Tuberculosis and Malaria
1290 Patients with cancer,
HIV, or MND, from
diagnosis until point
of death
60
MND = motor neurone disease.
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gested minor modification to the domain structure of
the MVQOLI may be appropriate in this sample. The
structure identified by the factor analysis suggested the
following factors: Interpersonal (items 11, 12, 13, 14 and
24), Function (items 2, 6, 7, and 8), Well being (items
16, 17, 18, 19 and 23), Symptoms (items 1, 3 and 4) and
Transcendent (items 21 and 22) (importance items (5,
10, 15, 20, 15) and the global QOL item were omitted
from the factor analysis in line with Schwartz et al [53]).
We therefore calculated modified subscale scores: the
mean score of the items within the subscale, calculated
using standardized ‘raw’ scores, i.e. all items scored on a
five point Likert scale (1 = worst possible, 5 = best pos-
sible). Internal consistency of the MVQOLI was high,
with a = 0.83 for the 20 items scored 1-5 (individual
factors: Interpersonal a =0 . 7 4 ,Function a = 0.75, Well
being a = 0.63, Symptoms a = 0.56, Transcendent a =
0.70). Subject to further testing and confirmation of this
factor structure in similar populations, this item group-
ing may improve the validity of the measure in sub-
Saharan contexts.
Following the results of the factor analysis, data are
analysed in this study using both the original domain
structure and scoring system of the MVQOLI and the
modified scoring and factors identified in our factor
analysis (see Analysis).
Demographic data Research nurses also collected
demographic data (see Table 2 for variables). In line
with international guidelines, we defined having an
AIDS diagnosis as having a CD4+ T-cell count below
200 cells/μ, or having had an AIDS-defining illness, e.g.
extrapulmonary tuberculosis. We used the ECOG Per-
formance Status to measure patient functional status
[54]. We elected to collect data on the number of chil-
dren that respondents were responsible for, rather than
number of biological children. This was because within
Africa multiple AIDS deaths within the same family and
Table 2 MVQOLI items and subscales
Subscale Item
Global QOL How would you rate your QOL?
Symptoms 1. My symptoms are adequately controlled
2. I feel sick all the time
3. I accept my symptoms as a fact of life
4. I am satisfied with current control of my symptoms
5. Despite physical discomfort, in general I can enjoy my days OR Physical discomfort overshadows any opportunity for enjoyment
Function 6. I am still able to attend to most of my personal needs by myself OR I am dependent on others for my personal care
7. I am still able to do many of the things I like to do OR I am no longer able to do many of the things I like to do
8. I am satisfied with my ability to take care of my basic needs
9. I accept the fact that I cannot do many of the things I used to do OR I am disappointed that I cannot do many of the things
I used to do
10. My contentment with life depends upon being active and being independent in my personal care
Interpersonal 11. I have recently been able to say important things to the people close to me
12. I feel closer to others in my life now than I did before my illness OR I feel increasingly distant from others in my life
13. In general, these days I am satisfied with relationships with family and friends
14. At present, I spend as much time as I want to with family and friends
15. It is important to me to have close personal relationships
Well being 16. My affairs are in order; I could die today with a clear mind OR My affairs are not in order; I am worried that many things are
unresolved
17. I feel generally at peace and prepared to leave this life OR I am unsettled and unprepared to leave this life
18. I am more satisfied with myself as a person now than I was before my illness
19. The longer I am ill, the more I worry about things ‘getting out of control’ OR The longer I am ill, the more comfortable I am
with the idea of ‘letting go’
20. It is important to me to be at peace with myself
Transcendent 21. I have a greater sense of connection to all things now than I did before my illness OR I feel more disconnected from all things
now than I did before my illness
22. I have a better sense of meaning in my life now than I have had in the past OR I have less of a sense of meaning in my life
now than I have had in the past
23. As the end of my life approaches, I am comfortable with the thought of my own death OR As the end of my life approaches,
I am uneasy with the thought of my own death
24. Life has become more precious to me; every day is a gift OR Life has lost all value for me; every day is a burden
25. It is important to me to feel that my life has meaning
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mean adults may care for children other than their own,
e.g. grandchildren, nephews and nieces.
Translation
The participating sites translated the MVQOLI and all
other study documentation from English into local lan-
guages (isiXhosa, isiZulu [Gauteng and KwaZulu Natal
dialects], isiSotho, Luganda, Runyankole and Runyoro).
Staff members who were fluent in both English and the
relevant local language cross-checked the translations,
focussing on conceptual equivalence [55]. The Univer-
sity of KwaZulu Natal conducted the KwaZulu Natal isi-
Zulu translation and the University of Cape Town
conducted the isiXhosa translation.
Data collection procedure
After receiving training on the administration of the
MVQOLI and the demographic questionnaire (LS), inde-
pendent researchers based at each site administered the
questionnaires, either in the participant’sh o m eo ra tt h e
site during a routine outpatient visit or inpatient admis-
sion. Patients were informed that participation in the
study would not influence the care they received. At site
A, two trained local interviewers assisted the researcher,
owing to the long distances between the catchment areas
of the service’s satellite clinics. At site E, one trained local
interviewer assisted, as the researcher did not speak
isiZulu.
The researchers entered anonymised quantitative data
into purpose-designed Excel spreadsheets, subsequently
imported into SPSS for analysis by LS. All data was stored
securely in locked filing cabinets or password-protected
files to ensure confidentiality. Data collection and entry
was overseen and checked by Principal Investigators at the
participating sites (ND, LG, LMS, TM, BI).
Analysis
Descriptive statistics
We described patients’ demographic profiles and
MVQOLI scores using descriptive statistics (frequency,
mean, standard deviation and median). In order to com-
pare importance scores across the subscales, we con-
ducted unpaired t-tests using mean scores, standard
deviations and sample sizes.
Comparison of sub-groups
As almost all cancer patients (n = 50) were recruited at
sites A, B and C, with 27%, 32.3% and 32.5% of cancer
patients recruited at each respectively, we compared
this cancer sample to HIV patients recruited at the
same services to minimise the risk of differences
between the sites confounding the findings. We used
non-parametric Mann-Whitney U tests to compare
scores on the MVQOLI subscales by diagnosis (cancer
vs. HIV), as the Kolmogorov-Smirnov test (with Lillie-
fors approximation) demonstrated that the distribution
of scores was skewed for all subscales, and we treated
t h eg r o u p sa si n d e p e n d e n ts a m p l e sg i v e no u ra t t e m p t
to minimise site effects. We hypothesised a difference
between HIV and cancer groups based on the literature
[56,57].
Associations between subscales and Total score
In order to determine the relationship between subscale
scores and Total QOL s c o r ew eu s e dt h eS p e a r m a n ’s
correlation to correlate mean subscale scores with mean
Total QOL score. We hypothesised moderate correla-
tions between subscale scores and total QOL score in
line with the original validation of the MVQOLI [43].
Comparison to other studies
In order to compare our findings to those of previous
studies, we conducted unpaired t-tests comparing our
MVQOLI data to that reported in other studies,
[43,44,58] for mean subscale, Total QOL and global
QOL scores, using standard deviations and sample sizes.
Throughout the analyses we use the original scoring
system for the MVQOLI in order to ensure data are
comparable with other studies utilising the tool. In
describing the population we also report modified sub-
scale scores based on the modified factors identified in
our previous factor analysis (see Instruments)[ 5 2 ] .T h e
modified subscale scores are not weighted according to
the importance of that domain to patients and are not
comparable to the scores reported in previous studies.
All analyses were conducted in SPSS v17 except
unpaired t-tests, which were conducted using GraphPad
software.
Results
Sample characteristics
Over a six week period, we recruited 285 patients across the
sites. None of the patients approached declined to take part.
Interviews were in seven languages: isiZulu (N = 143,
50.2%), isiXhosa (N = 41, 14.4%), English (N = 41, 14.4%),
isiSotho (N = 18, 6.3%), Runyoro (N = 15, 5.3%), Runyan-
kole (N = 14, 4.9%) and Luganda (N = 13, 4.6%).
Table 3 shows participants’ demographic characteris-
tics. 80.7% of patients had a primary diagnosis of HIV
and 17.9% a primary diagnosis of cancer; 15.2% of HIV
infected patients also had cancer. The most frequent
cancer diagnoses were cervical cancer (N = 32, 37.2%),
Kaposi’s Sarcoma (N = 8, 9.3%) and prostate cancer
(N = 7, 8.1%), reflecting the epidemiology of cancer in
the region and common malignancies in HIV [59]. Parti-
cipants reported 17 different first languages; the most
prevalent of these were isiZulu (N = 140, 49.1%), isiX-
hosa (N = 43, 15.1%), Runyoro (N = 20, 7.0%), Luganda
(N = 20, 7.0%) and Runyankole (N = 18, 6.3%).
Consideration of the 5th item of each MVQOLI sub-
scale, which assesses the subjective importance of the
domain in patients’ lives, shows that close relationships
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4.13, SD 0.69), closely followed by feeling at peace (item
20) (4.12, SD 0.69) and having a sense of meaning in life
(item 25) (4.10, SD 0.65), followed by being active (item
10) (3.84, SD 0.92), and physical comfort (item 5) (2.58,
SD 1.12). These items correspond to the Interpersonal,
Wellbeing, Transcendent, Function and Symptoms
domains respectively. None of the differences between
scores were significant at p < 0.05.
Comparison of the mean scores on the MVQOLI sub-
scales shows that patients scored most poorly (i.e. with
least positive contribution to QOL) on the Function
subscale, followed by Well being, Symptoms, Transcen-
dent and Interpersonal subscales (Table 4). However,
relatively high mean subscale scores may mask a signifi-
cant proportion of patients scoring poorly on individual
items. For example, 165 patients (57.9%) agreed/agreed
strongly with the statement ‘The longer I am ill, the
more I worry about things ‘getting out of control’’ (item
19); 115 (40.4%) patients agreed/agreed strongly with
‘I feel more disconnected from all things now than I did
before my illness’ (item 21); and 78 (30.9%) agreed/
agreed strongly with ‘I have less of a sense of meaning
in my life now than I have had in the past’ (item 22).
Scores for the modified MVQOLI factors based on
[52] are presented in Table 5. Symptom and Interperso-
nal scores on the modified factors were relatively high,
while Function score was low. Modified subscale scores
for the other two domains lie between these values. As
weighting items are removed in the modified subscales,
these scores do not reflect the subjective importance of
the domain to patients’ QOL, with consequent variation
in the relative ranking of the original and modified
mean subscale scores.
Comparison of sub-groups
Comparison of scores by diagnosis showed that patients
with cancer at sites A, B and C scored significantly
higher (i.e. better) than patients with HIV infection at
those sites on Wellbeing (Z =- 2 . 7 7 8 ,p=0 . 0 0 5 )a n d
Transcendent (Z = -2.693, p = 0.007) subscales, and on
Total QOL score (Z = -2.564, p = 0.01) (Table 4).
Associations between subscales and Total score
Correlations between subscale scores and Total QOL
were as follows: Transcendent (r = 0.768); Well being
(0.719), Interpersonal (0.661), Function (0.604) and
Symptoms (0.382). The global QOL score was most
weakly correlated with Total QOL (r = 0.365). All corre-
lations were significant (p < 0.001).
Comparison to other studies
Table 6 compares the subscale, Total and global QOL
scores from this study with those from other studies
using the MVQOLI [43,44,58]. The American studies
involved advanced cancer [58] and mixed advanced
cancer and organ failure populations, [43] while the
Ugandan study surveyed advanced AIDS patients using
a modified but comparable version of the MVQOLI
[44].
Table 3 Demographic characteristics
Demographic characteristic Patients (N = 285)
Age
Mean (SD) 40.1 (12.8)
Range 18-88
Gender
Female 197 (69.1%)
Responsible for children?
Yes 232 (81.4%)
Mean no. children (SD) 3.1 (2.0) 1-12
Range
Household size
Mean (SD) 5.3 (2.5)ª
Range 1-14ª
Location of home
Urban 53 (18.6%)
Peri-urban 53 (18.6%)
Rural 179 (62.8%)
Primary diagnosis
MND 1 (0.4%)
Korsakoff’s syndrome 1 (0.4%)
Multiple Sclerosis 1 (0.4%)
Systemic lupus erythematosus 1 (0.4%)
Cancer only 51 (17.9%)
HIV 230 (80.7%)
Of HIV+ pts: On ART 127 (55.2%)
b
Prior AIDS diagnosis 192 (83.5%)
Dual HIV-cancer diagnosis 35 (15.2%)
ECOG Functional status
Fully active 21 (7.4%)
Restricted 65 (22.8%)
Ambulatory 79 (27.7%)
Limited self care 87 (30.5%)
Completely disabled 33 (11.6%)
Primary place of palliative care
Home 180 (63.2%)
Inpatient 74 (26%)
Outpatient 13 (4.6%)
Day care 18 (6.3%)
Weeks under palliative care
Mean (SD) 46.0 (74.8)
Median 12.0
Range 0-468
ª3 missing.
b1 missing.
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The mean global QOL score among patients in South
Africa and Uganda who were recruited into this study
was 2.81 out of a maximum of 5, and the mean Total
QOL score was 17.32 (possible range 0 to 30). Overall,
patients in this study exhibited relatively poor QOL in
comparison to studies using the MVQOLI in the USA
(Table 6). In particular, mean Interpersonal and Trans-
cendent scores were significantly lower in our sample
than in all previous studies using the MVQOLI both in
the USA [43,58] and Uganda, [44] indicating worse
QOL in these domains. Our data go against the findings
of a qualitative study in Kenya which found that
patients’ psychological, social and spiritual needs were
met by family members, the community and faith
groups, [31] and suggest that this is not always the case.
The mean Transcendent score in our study (5.50) is
especially low given the next lowest mean score found
on this subscale was 14.10, reported by Steele et al in
their study of home hospice cancer patients in the USA
[58].
However, overall, patients in our study reported signif-
icantly better scores on the Symptom subscale than
AIDS patients in Uganda and home hospice patients’ in
Steele et al’s USA study [58]. Patients in our study also
had significantly better functional and psycho-spiritual
wellbeing than AIDS patients in the Ugandan study
[44]. This may relate to the physical and psychological
burden of living with AIDS and the fact that the
patients in the Ugandan study were not receiving pallia-
tive care.
As in the Ugandan study, we found that the poorest
QOL was reported in the function domain, followed by
psycho-spiritual wellbeing (as measured by the Well being
subscale), then physical symptoms. These domains were
also the worst three in the US studies; however, in a differ-
ent order: Byock and Merriman report poorest QOL in
function, symptoms, and then psycho-spiritual well being;
Steele et al report poorest QOL in psycho-spiritual well
being, function, and then symptoms. However, in our
study scores in the spiritual domain (measured by the
Transcendent subscale) were also notably low, while in the
other studies this was not the case [43,44,58].
Despite the pain and symptoms associated with incur-
able, progressive disease, physical comfort and being
active were judged by participants in this study to be
less important to QOL than close relationships, feeling
at peace and having a sense of meaning in life, as shown
by the relatively low scores on importance items 5 and
10, although these differences were not statistically sig-
nificant. This is also reflected in the results of the corre-
lation, which show that the Transcendent, Wellbeing
Table 4 MVQOLI scores overall and comparison by diagnosis (Mann-Whitney U test)
MVQOLI score Overall mean (SD) (N = 285) Cancer mean (SD) (N = 50) HIV mean (SD) (N = 115) P Z
Global QOL 2.81 (1.04) 2.94 (0.98) 2.90 (0.95) 0.78 -0.279
Symptom subscale 5.38 (7.32) 7.68 (7.73) 5.88 (8.49) 0.49 -0.694
Function subscale 0.21 (11.62) 1.04 (10.68) -1.10 (11.71) 0.96 -0.051
Interpersonal subscale 9.53 (12.78)
a 14.52 (11.15) 11.18 (11.91)
a 0.07 -1.846
Well being subscale 2.59 (12.12) 3.95 (12.17) -1.75 (12.69) 0.005* -2.778
Transcendent subscale 5.50 (12.03)
c 8.79 (13.37)
b 5.57 (11.23)
d 0.007* -2.693
Total score 17.32 (3.70)
e 18.44 (3.64)
b 16.94 (3.61)
c 0.01* -2.564
*Significant at p < 0.05.
aMissing n = 2.
bMissing n = 1.
cMissing n = 8.
dMissing = 7.
eMissing n = 9.
Table 5 Scores for modified MVQOLI factors (based on [52], N = 285)
Modified MVQOLI subscale score* Items Mean (SD) Median Interquartile range Respondent range
Modified Symptom subscale 1, 3, 4 3.69 (0.71) 4.0 3.33-4.00 1-5
Modified Function subscale 2, 6, 7, 8 2.83 (0.91) 2.75 2.00-3.50 1-4.75
Modified Interpersonal subscale 11, 12, 13, 14, 24 3.62 (0.78)
a 3.80 2.60-3.80
a 1.2-5
a
Modified Well being subscale 16, 17, 18, 19, 23 3.18 (0.81)
b 3.20 2.60-3.80
b 1-5
b
Modified Transcendent subscale 21, 22 3.25 (1.05)
a 3.50 2.00-4.00
a 1-5
a
*Mean score for included items (raw scores used for all items: 1 (worst possible) - 5 (best possible)).
aMissing n = 2.
bMissing n = 7.
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Page 8 of 14Table 6 Comparison with MVQOLI subscale scores from other studies
Study Sample (N) Symptoms Function Interpersonal Well being Transcendent Total Global QOL
This study Palliative care patients, South Africa &
Uganda (N = 285 unless stated)
Mean (SD) 5.38 (7.32) 0.21 (11.62) 9.53 (12.78) 2.59 (12.12) 5.50 (12.03) 17.32 (3.70) 2.81 (1.04)
Namisango et al 2007 [44] Advanced AIDS patients receiving HIV care
from community/home/outpatient clinic,
Uganda (N = 200)
Mean (SD) 1.70 (9.83) -2.05 (10.81) 17.44 (13.03) -1.39 (12.90) 16.08 (12.99) 16.27 (3.38) 2.68 (0.95)
T (p) 4.72 (<0.001) 2.17 (0.03) 6.65 (<0.001) 3.47 (<0.001) 9.16 (<0.001) 3.17 (0.002) 1.40 (0.16)
Byock & Merriman 1998 [43] Community-based hospice patients, 68%
advanced cancer, 11% end-stage lung
disease, 8% end-stage heart disease, USA (N
= 173)
Mean (SD) 6.19 (7.32) 6.09 (15.27) 17.64 (10.92) 5.01 (14.45) 14.10 (13.00) 19.91 (3.97) 3.39 (1.07)
T (p) 1.15 (0.25) 4.65 (<0.001) 6.94 (<0.001) 1.92 (0.06) 7.15 (<0.001) 7.02 (<0.001) 5.72 (<0.001)
Steele et al 2005 [58] Home hospice patients, 92.6% advanced
cancer, 3.9% HIV, 3.1% COPD, 0.4% other,
USA (N = 129)
Mean (SD) 3.16 (7.87) 1.72 (15.91) 14.01 (11.11) 4.29 (14.46) 15.55 (11.61) Not reported Not reported
T (p) 2.79 (0.006) 1.09 (0.28) 3.43 (<0.001) 1.24 (0.21) 7.92 (<0.001)
Note: Mean scores which are significantly higher than in our study are in bold; mean scores which are significantly lower are italicised.
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4and Interpersonal subscales are most highly correlated
with Total QOL, with spiritual and psycho-spiritual
domains reaching levels of strong correlation (r > 0.7).
Our findings support other studies suggesting that phy-
sical symptoms and function are not as important to
patients with life-limiting illness as other domains of
QOL [60-63]. This finding could be due to the accep-
tance of discomfort and physical limitation and the re-
evaluation of goals that can occur through ‘response
shift’ [64,65]. There is evidence that cancer patients tend
to readjust expectations to fit their current health and
functional status, [66] and that patients in palliative care
shift their values away from self-enhancement (e.g.
power) and towards self-transcendence (e.g. benevo-
lence) [67]. These findings may reflect coping processes
in the face of the uncertainty of living with an incurable,
progressive disease [68].
Owing to the lower scores on importance items 5 and
10, the symptoms and function domains were accorded
less weight in calculating the Total QOL score than the
non-physical domains. However, despite this the Symp-
toms and Function subscales showed poor mean scores.
This suggests that even if response shift or adaptation is
evident in the relative importance allocated to the five
domains, patients in this study nevertheless experienced
considerable suffering and reduction of their QOL
owing to uncontrolled or unacceptable symptoms and
physical function.
Close relationships, feeling at peace and having a
sense of meaning in life were rated as highly important
by patients (mean 4.13, 4.13 and 4.10 out of 5 respec-
tively). This supports the findings of other studies
regarding the importance of interpersonal and spiritual
domains in incurable progressive disease [35,61,69-71].
Our findings also suggest that patients with HIV receiv-
ing palliative care in South Africa and Uganda may experi-
ence poorer QOL than patients with cancer. HIV-infected
patients scored significantly worse than cancer patients on
Well being, Transcendence and Total QOL. In the USA, a
study by Sherman et al found that patients with AIDS had
lower total QOL scores, and lower psychological QOL
than patients with advanced cancer; however, patients
with AIDS had higher physical QOL scores [72]. In a
study of 2,864 HIV-infected adults in the USA, Hays et al
found that patients with AIDS had significantly worse phy-
sical functioning and emotional well being than patients
with prostate cancer [57]. Our findings also support those
of other studies in sub-Saharan Africa documenting the
psychological and spiritual burden of living with HIV [32]
and the need for support in these areas [73-75].
Modified subscale scores based on factor analysis in
this sample and reported elsewhere [52] suggest that
symptom control/acceptance of symptoms and interper-
sonal well being are relatively good, while physical
function and acceptance of physical limitations is poor.
Unlike the subscales in the original tool, the modified
subscale scores are not weighted according to the subjec-
tive importance of the domains, and this should be noted
when interpreting the modified scores. For example,
although overall patients rate highest on symptoms and
interpersonal well being with respect to the modified
scores, once the weighting aspect is taken into considera-
tion the beneficial impact of symptom control/accep-
tance of symptoms falls: interpersonal well being, rather
than symptoms, has a more positive effect on QOL when
the original tool scoring system is used.
Finally, it is interesting that global QOL as assessed
b yi t e m1o ft h eM V Q O L I( ’How would you rate your
overall QOL?’) was poorly correlated with Total QOL
(r = 0.37). A relatively low correlation between Total
QOL and global QOL (r = 0.43) was also reported in
the original validation of the tool in the USA [46],
although this was higher (0.58) in the Ugandan study
of advanced AIDS patients [44]. In our study setting
the poor correlation between global QOL and Total
QOL could suggest that the Total QOL score measures
a construct different to QOL as understood by study
participants. One reason may be that the tool does not
assess socio-economic factors which might be of parti-
cularly relevance to patients in a resource-constrained
setting. Hunger and stigma, for example, are prevalent
in this population [44,45] and could adversely affect
QOL in a way not assessed by the MVQOLI in its cur-
rent format.
Limitations
Our study may have overestimated QOL in patients
receiving palliative care in sub-Saharan Africa. South
Africa and Uganda, where this study was conducted, are
widely recognised as the two African countries with the
most advanced provision of palliative care [6]. The ser-
vices involved were not selected randomly; hence find-
ings may not be generalisable across palliative care
services in the two countries. Participating sites were
some of the most well-established palliative care services
in South Africa and Uganda; patients in this study are
therefore likely to be receiving relatively high quality pal-
l i a t i v ec a r ea n dm a yh a v eh igher QOL than patients at
other services. In addition, patients were required to be
well enough to participate in self-report data collection,
which may bias our data against those with significant
disease progression and nearing the end of life, who may
have poorer QOL than patients in this sample. As our
findings relate to patients receiving palliative care, it is
worth noting that other people with life-limiting illness
in sub-Saharan Africa have less access to care than this
sample, and hence are likely to have poorer QOL [5].
Further studies are required in other African settings.
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Page 10 of 14Owing to resource constraints we were not able to use
the best practice methods of double data entry and tool
adaptation involving multiple translations, synthesis of
translations, back translation, expert committee review
and pretesting prior to psychometric testing of the
MVQOLI [76]. Two academic departments carried out
two of the translations. To minimise inaccuracies, all
translations were cross-checked by bilingual palliative
care staff and difficulties in translation were resolved
through discussion with the local research team. While
the factor analysis suggested the tool might be psycho-
metrically appropriate for measuring QOL in this con-
text, the translations utilised in this study would benefit
from further investigation and cognitive testing in the
future. The interpretation of our findings is therefore
subject to modification on the basis of further testing of
the MVQOLI in South African and Ugandan popula-
tions in the future.
Another limitation relates to the small cancer sample
(n = 50) used when comparing MVQOLI scores in can-
cer and HIV diagnoses. As data were collected as part
of a larger study focussing on psychometrics, no power
calculation was used to determine sample size for this
survey; hence our comparison of QOL domains by diag-
nosis should be interpreted cautiously. However, our
comparison showed highly significant differences
between the HIV and cancer samples for three out of
six variables, despite the limited sample size.
The heterogeneity of the services and the populations
they care for also affects the generalisability of findings.
For example, at site D patients were recruited relatively
close to admission (mean 2.9 weeks, SD 5.1), while
patients at site E had been under palliative care for a
mean of 122.3 weeks (SD 100.6). To take account of
these variations we limited our comparison of cancer and
HIV sub-groups to those services where the majority of
cancer patients were recruited. However, there are likely
to be demographic differences between patients in the
two groups (e.g. gender, age) which we were not able to
take into account in our analyses, hence our comparative
findings should be interpreted with caution.
Finally, we used parametric t-tests to check for the
significance of differences between our results and those
of other studies (Table 6), despite a lack of normality in
the MVQOLI distributions in our study. However, this
was the only comparison possible given the data
reported in other studies.
Clinical implications
Our findings suggest that patients receiving palliative care
in South Africa and Uganda have poor QOL as measured
by the MVQOLI. While physical function was the domain
with the least positive impact on QOL in this study (Func-
tion subscale mean 0.21), psycho-spiritual well being had
the next least positive contribution (Wellbeing subscale
mean 2.59). These findings show that it is vital to identify
and meet the psychological and spiritual care needs of
patients, as well as to rigorously assess and treat pain and
other symptoms, and support patients in coping with their
functional limitations. This requires multi-dimensional
palliative care provided by a multi-professional team.
Palliative care providers in sub-Saharan Africa are directed
to local guidance on supportive and palliative care [77],
spiritual care [78], and counselling [79].
The significantly worse scores on Symptoms, Interper-
sonal and Transcendent subscales among HIV infected
patients compared to cancer patients support other stu-
dies reporting high levels of physical and psychosocial
symptoms [32,80,81] and spiritual concerns [82] in HIV.
Population level findings should be interpreted with cau-
tion clinically, as we found that relatively high mean sub-
scale scores may mask a significant proportion of patients
scoring poorly on individual items. Individual levels of
QOL depend on a host of contextual factors, such as
patient history, family and community relationships, and
spiritual beliefs. The heterogeneity of patient experiences
should therefore be taken into account by ensuring that
multi-dimensional needs are assessed regularly and that
care is patient-centred and tailored to individual patient
and family needs.
Future research
On the basis of our findings we recommend the following
areas for future research. First, research is needed to
explore the QOL of patients receiving palliative care in
sub-Saharan Africa in different settings and using different
models of care. Research focussed on specific settings and
population groups would enable demographic and clinical
predictors of QOL to be identified. Second, our findings
support the need for research into psychological and spiri-
tual aspects of patients’ illness experience, as these
areas are highly important to patients, are rated relatively
poorly as domains of QOL, and are currently neglected in
palliative care research in Africa. Third, our finding that
physical function as measured by the MVQOLI has a sig-
nificant negative effect on patients’ QOL warrants further
research. For example, it would be useful to explore cur-
rent occupational therapy, counselling and home care pro-
vision in sub-Saharan Africa and evaluate the effect of
these interventions on the functional domain of patients’
QOL. Finally, future studies are needed to examine and if
necessary improve the translations of the MVQOLI used
in this study, explore the comprehension of specific trans-
lations through cognitive interviewing, and conduct
further testing of the tool’s validity, reliability and appro-
priateness, including assessment of weighting and scoring
systems and exploration of factor loadings in populations
from different African countries.
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Patients receiving palliative care in South Africa and
Uganda have poor QOL as measured by the MVQOLI,
and in comparison to hospice patients in the USA.
Patients with HIV infection in this population may be at
increased risk of poor QOL when compared to patients
with a primary diagnosis of cancer, particularly with
respect to psychological and spiritual domains.
In this study, close relationships, feeling at peace and
having a sense of meaning in life were overall more
important to patients than being active or physical com-
fort, indicating the particular relevance of family, friends
and spiritual concerns in this patient group. This sup-
ports the need for QOL scales to include psychosocial
and spiritual items and not to neglect these aspects of
patient experience by focussing solely on physical symp-
toms. It is vital to identify and meet the psychological
and spiritual care needs of patients, as well as to assess
and manage pain and other symptoms and functional
limitations in this population. QOL is a key outcome of
palliative care and should be assessed in future research
evaluating interventions and models of care in Africa, in
order to inform the provision of palliative care in the
region.
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